TrialThe Journal of infectious diseases2011

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.

Hiroyu Hatano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.